Literature DB >> 22825038

Potential value of dual-time-point ¹⁸F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis.

Yu-Yi Lin1, Jin-Hua Chen, Hueisch-Jy Ding, Ji-An Liang, Jun-Jun Yeh, Chia-Hung Kao.   

Abstract

We performed a meta-analysis to assess the potential value of dual-time-point (DTP) imaging as compared with initial single-time-point (STP) scanning with 18F-fluorodeoxyglucose (18F-FDG) PET in differentiating malignant from benign single pulmonary nodules. Data on the performance of DTP 18F-FDG PET imaging in assessing lung nodules were extracted from articles of prospective or retrospective original research published between January 2001 and April 2010. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool was used to assess the quality of study methodology. Heterogeneity in the results of the studies was assessed, and summary receiver operating characteristic (SROC) curves were constructed. Eleven studies comprising a total of 788 patients who underwent initial scanning, 778 of whom also underwent DTP imaging, were included in the final analysis. The quality of study methodology was judged to be moderate. Substantial heterogeneity in the results of the studies, with inconsistency (I2) index values above 85%, reflected important differences in study methods and populations, including varying lesion sizes, 18F-FDG avidity, uptake interval for delayed imaging, and threshold for positive result on DTP imaging. SROC curve analysis revealed a statistically nonsignificant trend toward higher sensitivity with DTP imaging, at moderate levels of specificity, when compared with initial STP scanning. The area under the curve (SE) values for DTP and initial STP imaging were 0.839 (0.079) and 0.757 (0.074), respectively. Although the results of our analysis do not support the routine use of DTP imaging with 18F-FDG PET in the differential diagnosis of pulmonary nodules, this technique may provide additional information in selected cases with equivocal results from initial scanning. Further prospective research is required to better define the potential benefits of DTP 18F-FDG PET imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825038     DOI: 10.1097/MNM.0b013e32835710d6

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  10 in total

1.  Value of delayed 18F-FDG PET in the diagnosis of solitary pulmonary nodule.

Authors:  Ali Nawaz Khan; Hamdan Al-Jahdali
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.

Authors:  Sinae Lee; Taegyu Park; Soyeon Park; Kisoo Pahk; Seunghong Rhee; Jaehyuk Cho; Eugene Jeong; Sungeun Kim; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

3.  Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Authors:  Carryn M Anderson; Tangel Chang; Michael M Graham; Michael D Marquardt; Anna Button; Brian J Smith; Yusuf Menda; Wenqing Sun; Nitin A Pagedar; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

Review 4.  Diagnosis and evaluation of gastric cancer by positron emission tomography.

Authors:  Chen-Xi Wu; Zhao-Hui Zhu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  The clinical value of texture analysis of dual-time-point 18F-FDG-PET/CT imaging to differentiate between 18F-FDG-avid benign and malignant pulmonary lesions.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

6.  A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules.

Authors:  Jason Callahan; Tomas Kron; Michal E Schneider; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2014-06-05       Impact factor: 3.909

Review 7.  Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.

Authors:  Filippo Lococo; Barbara Muoio; Marco Chiappetta; Dania Nachira; Leonardo Petracca Ciavarella; Stefano Margaritora; Giorgio Treglia
Journal:  Contrast Media Mol Imaging       Date:  2020-04-25       Impact factor: 3.161

Review 8.  Evaluation of tumor response after stereotactic body radiation therapy for lung cancer: Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Pino Alcantara; Beatriz Cabeza Martínez; Marta García García-Esquinas; Laura G Belaústegui; Ana Bustos
Journal:  J Clin Transl Res       Date:  2020-10-06

9.  Dual time point based quantification of metabolic uptake rates in 18F-FDG PET.

Authors:  Jörg van den Hoff; Frank Hofheinz; Liane Oehme; Georg Schramm; Jens Langner; Bettina Beuthien-Baumann; Jörg Steinbach; Jörg Kotzerke
Journal:  EJNMMI Res       Date:  2013-03-13       Impact factor: 3.138

Review 10.  Absolute Quantification in Diagnostic SPECT/CT: The Phantom Premise.

Authors:  Stijn De Schepper; Gopinath Gnanasegaran; John C Dickson; Tim Van den Wyngaert
Journal:  Diagnostics (Basel)       Date:  2021-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.